MILTEFOSINE

img

What is Lorem Ipsum?

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.

MILTEFOSINE

✅ MILTEFOSINE (CAS 58066-85-6) – PRODUCT DESCRIPTION

Miltefosine (CAS 58066-85-6) is an antiparasitic drug primarily used in the treatment of leishmaniasis, including visceral leishmaniasis, cutaneous leishmaniasis, and mucocutaneous leishmaniasis caused by Leishmania species. It is the first oral medication approved for the treatment of leishmaniasis, working by disrupting the membrane integrity of Leishmania parasites, ultimately preventing their replication and growth. Miltefosine is also being investigated for its anticancer potential, as it has shown efficacy in inducing apoptosis in cancer cells. This white to off-white crystalline powder is available in pharmaceutical grades (IP/BP/USP/EP), ensuring high purity for use in oral tablets, capsules, and injectable solutions. We supply Miltefosine to pharmaceutical manufacturers, healthcare providers, and research organizations globally, ensuring reliable and high-quality supply to USA, Malaysia, Vietnam, and Chile.

📦 Industries Used In:

  • Pharmaceuticals (treatment of leishmaniasis, including visceral leishmaniasis and cutaneous leishmaniasis)

  • Healthcare (used for cancer treatment and parasitic infections management)

  • Research (studies on antiparasitic treatments, anticancer drug development, and apoptosis mechanisms)

  • Manufacturing (production of oral tablets, capsules, and injectables for leishmaniasis and cancer treatment)

🧪 Available Grades:

  • Pharmaceutical Grade (IP/BP/USP/EP)

  • Reagent Grade

  • Laboratory Grade

⚙️ Functions:

  • Antiparasitic agent used to treat leishmaniasis caused by Leishmania parasites

  • Induces apoptosis in cancer cells, making it a potential anticancer agent

  • Disrupts cellular membrane integrity of parasites and inhibits parasite growth

  • Reagent in antiprotozoal drug research, cancer therapy studies, and antiparasitic drug development

  • **Used for the treatment of visceral and cutaneous forms of leishmaniasis and mucocutaneous leishmaniasis

🧩 Classified Under:

 

  • Pharmaceuticals

  • Antiparasitic Medications

  • Cancer Medications

  • Active Pharmaceutical Ingredients (APIs)

  • Infectious Disease Treatments

CAS Number

58066-85-6

Formula

C21H46NO4P

Molecular Weight

413.57 g/mol

Density

1.02 g/cm³

Gravity

~1.02

Melting Point

~108-110°C

Partical Size

White to off-white crystalline powder
Get Quote